Marin Marijuana Legalization is Corporatization of Cannabis

2019-01-23T14:15:44-06:00February 16th, 2017|Marijuana, Medical Cannabis|

http://www.marinij.com/general-news/20170215/marin-marijuana-legalization-debated-on-ij-forums Don Carney says he prefers to call the legalization of marijuana the “corporatization” of cannabis. That’s because, as laws are relaxed and it becomes more readily available, the active ingredient — tetrahydrocannabinol, or THC — is working its way into all kinds of consumer products, says Carney, director of restorative services and the Marin [...]

Pharmacists Rank Second Again Among Gallup’s Most Trusted Professionals

2019-07-16T16:20:06-05:00November 21st, 2016|Acute Care, ADD/ADHD, Administration/Management, Adverse Drug Reactions, AIDS / HIV, Allergies, Alternative Medicine, Alzheimers/Dementia, Asthma, Compliance, Compounding, COPD, Cultural Diversity, Depression/Bipolar, Diabetes, Dyslipidemia / Cholesterol, E-Prescribing, Endocrinology, Ethics, Hepatitis C, HIPAA, Hypertension / Blood Pressure, Immunizations, Infertility, Marijuana, Marijuana Legalization, Medical Cannabis, Medication Safety, Men's Health, Mental Health, Naloxone, Nutrition, Obesity / Weight management, Opioid Epidemic, Opioid Safety, Pain Management, Pallative Care / Hospice, Pharmaceutical TakeBack, Pharmacist Training, Pharmacists, Pharmacy Law, Preceptor/Mentor Training, Prescription Cost, Prescription Drug Errors, Preventative Care, Provider Status, Public/Community Health, Regulatory Issues, Rheumatology, Risk Management, Smoking Cessation, Sports Medicine, STD's, Substance Abuse, Technology, Telemedicine / Telepharmacy, USP 795, USP 797, USP 800, Veterinary Pharmacy - Exotics, Veterinary Pharmacy - Large Animals, Veterinary Pharmacy - Small Animals, Womens Health|

Top-three recognition for 14th straight year shows importance of pursuing a pro-pharmacy, pro-patient policy agenda, NACDS says 12.21.2016 "The takeaway for policymakers is that the pharmacist-patient relationship has tremendous potential to do even more to improve patient health and well-being, along with the overall quality and affordability of healthcare." click here to read the story 

First pre-regulatory stakeholder meetings w/ Bureau of Medical Cannabis Regulation-Sept & Oct

2020-06-24T16:50:08-05:00September 12th, 2016|Medical Cannabis, Pharmacists|

The Bureau of Medical Cannabis Regulation (BMCR) and Office of Medical Cannabis Safety (OMCS) will be holding their first pre-regulatory stakeholder meetings this September and October. Discussing issues related to general licensing requirements, and specific concepts related to the regulation of medical cannabis dispensaries, distributors, manufacturers, testing laboratories and transporters. Please join us for one of [...]

Go to Top